Russell Jared Koesterich
Russell Jared Koesterich's purchase track record
How the stock did after each of Russell Jared Koesterich's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/22/2021 | BCAT | $39K | -7.2% | -17.3% | -6.0% |
| 9/28/2021 | BCAT | $39K | -2.9% | -12.6% | +6.4% |
| 9/17/2021 | BCAT | $103K | -8.5% | -16.8% | +0.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
BCAT Announces Rights Offering Amid Low RSI. BlackRock Capital Allocation Term Trust has launched a rights offering, a move often used by closed-end funds to raise capital or adjust leverage. This corporate action is the primary driver behind recent market attention for the stock. While the fund trades at a low RSI of 22.1, indicating recent selling pressure, the rights offering represents a significant structural event for shareholders.
Transaction History
| ECAT | ▲ Buy | Option Exercise | 5,135 | — | 1/30/2026 | View on chart |
| BCAT | ▲ Buy | Option Exercise | 5,554 | — | 1/30/2026 | View on chart |
| BCAT | ▼ Sell | Other | 5,554 | $82K | 1/30/2026 | View on chart |
| ECAT | ▼ Sell | Other | 5,135 | $79K | 1/30/2026 | View on chart |
| BCAT | ▼ Sell | Other | 1,713 | $26K | 1/31/2025 | View on chart |
| BCAT | ▲ Buy | Option Exercise | 1,713 | — | 1/31/2025 | View on chart |
| ECAT | ▲ Buy | Option Exercise | 1,587 | — | 1/31/2025 | View on chart |
| ECAT | ▼ Sell | Other | 1,587 | $26K | 1/31/2025 | View on chart |
| BCAT | ▲ Buy | Open Market | 400 | $8K | 10/22/2021 | View on chart |
| BCAT | ▲ Buy | Open Market | 200 | $4K | 10/22/2021 | View on chart |
| BCAT | ▲ Buy | Open Market | 948 | $19K | 10/22/2021 | View on chart |
| BCAT | ▲ Buy | Open Market | 25 | $492 | 10/22/2021 | View on chart |
| BCAT | ▲ Buy | Open Market | 227 | $4K | 10/22/2021 | View on chart |
| BCAT | ▲ Buy | Open Market | 100 | $2K | 10/22/2021 | View on chart |
| BCAT | ▲ Buy | Open Market | 100 | $2K | 10/22/2021 | View on chart |
| BCAT | ▲ Buy | Open Market | 2,000 | $39K | 9/28/2021 | View on chart |
| BCAT | ▲ Buy | Open Market | 3,000 | $61K | 9/22/2021 | View on chart |
| BCAT | ▲ Buy | Open Market | 901 | $19K | 9/17/2021 | View on chart |
| BCAT | ▲ Buy | Open Market | 1,099 | $23K | 9/17/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
ECAT: BlackRock Closed-End Funds Announce Distribution Sources
The trust announced that its closed‑end funds will distribute income from specific sources, giving investors clearer insight into where the cash flow comes from. Knowing the distribution origins can help assess the trust’s stability and potential return. The disclosure comes as the shares trade near a key support level and a low RSI, indicating a possible consolidation phase. Overall, the update adds transparency to the trust’s income profile.
ECAT: BlackRock Closed-End Funds Announce Distribution Sources. The trust announced that its closed‑end funds will distribute income from specific sources, giving investors clearer insight into where the cash flow comes from. Knowing the distribution origins can help assess the trust’s stability and potential return. The disclosure comes as the shares trade near a key support level and a low RSI, indicating a possible consolidation phase. Overall, the update adds transparency to the trust’s income profile.